Cancer
Malignant Gastric Neoplasm
CI-CAN-00001130Explore in graph →
Top-level652 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001130Explore in graph →
Clinical trials
2,842 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (232)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06392750 | PWP1's Expression in Gastric Cancer. | completed | — | 200 | Northern Jiangsu People's HospitalOTHER | 1 | Apr 30, 2024 | clinicaltrials |
| NCT04742959 | Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 203 | TransThera Sciences (Nanjing), Inc.INDUSTRY | 1 | Apr 26, 2024 | clinicaltrials |
| NCT03330561 | PRS-343 in HER2-Positive Solid Tumors | completed | Phase 1 | 85 | Pieris Pharmaceuticals, Inc.INDUSTRY | 1 | Apr 22, 2024 | clinicaltrials |
| NCT03650348 | PRS-343 in Combination With Atezolizumab in HER2-Positive Solid Tumors | completed | Phase 1 | 41 | Pieris Pharmaceuticals, Inc.INDUSTRY | 1 | Apr 22, 2024 | clinicaltrials |
| NCT05336058 | Development of Free DNA Multi-target Methylated PCR for Auxiliary Diagnosis of Gastric Cancer | completed | — | 1,140 | Singlera Genomics Inc.INDUSTRY | 1 | Apr 22, 2024 | clinicaltrials |
| NCT06376773 | Neoadjuvant Treatment Based on Gastric Cancer Molecular Subtyping. | completed | — | 234 | Fujian Medical UniversityOTHER | 1 | Apr 19, 2024 | clinicaltrials |
| NCT05540145 | Neo-Sequence 1: Neoadjuvant Chemotherapy With or Without Antiangiogenesis and Sequential Immunotherapy for HER2-negative MMR-proficient Locally Advanced Gastric or Gastroesophageal Adenocarcinoma | completed | — | 70 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Apr 16, 2024 | clinicaltrials |
| NCT06365814 | ERAS for Gastric Cancer Patients After NACT | completed | — | 252 | The Affiliated Hospital of Qingdao UniversityOTHER | 1 | Apr 15, 2024 | clinicaltrials |
| NCT04768218 | BLI for the Diagnosis of Precancerous Conditions | completed | — | 102 | Instituto Portugues de Oncologia, Francisco Gentil, PortoOTHER | 1 | Mar 29, 2024 | clinicaltrials |
| NCT06337266 | A Novel Online Calculator to Predict Long-term Survival and Recurrence Risk of Patients With Gastric Adenocarcinoma | completed | — | 3,622 | Fujian Medical UniversityOTHER | 1 | Mar 29, 2024 | clinicaltrials |
| NCT06337279 | Systemic Oxidative Stress Score as a Predictor of Gastric Cancer Survival and Recurrence Risk | completed | — | 3,820 | Fujian Medical UniversityOTHER | 1 | Mar 29, 2024 | clinicaltrials |
| NCT03329950 | A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies | completed | Phase 1 | 132 | Celldex TherapeuticsINDUSTRY | 1 | Mar 28, 2024 | clinicaltrials |
| NCT05035602 | Google Location History Following Oesophagectomy and/or Gastrectomy | completed | — | 3 | Imperial College LondonOTHER | 1 | Mar 27, 2024 | clinicaltrials |
| NCT04547153 | Infusional Fluorouracil and Weekly Docetaxel for Gastric Cancer With Bone Marrow Involvement and DIC | completed | Phase 2 | 24 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Mar 25, 2024 | clinicaltrials |
| NCT01924533 | Efficacy and Safety Study of Olaparib in Combination With Paclitaxel to Treat Advanced Gastric Cancer. | completed | Phase 3 | 525 | AstraZenecaINDUSTRY | 4 | Mar 22, 2024 | clinicaltrials |
| NCT05030870 | Capnographic Monitoring in Gastrointestinal Endoscopy for Elderly Patients(CapnoGI) | completed | N/A | 1,800 | RenJi HospitalOTHER | 1 | Mar 19, 2024 | clinicaltrials |
| NCT03342937 | KeyLargo: Pembrolizumab + Oxaliplatin + Capecitabine in Gastric Cancer | completed | Phase 2 | 36 | Duke UniversityOTHER | 1 | Mar 13, 2024 | clinicaltrials |
| NCT01679054 | Cost-minimization Analysis of Gastric Cancer Treatments in Hong Kong | completed | — | 58 | Vivian Wing Yan LeeOTHER | 1 | Mar 12, 2024 | clinicaltrials |
| NCT03619681 | Trial of KN026 in Patients With HER2-positive Advanced Malignant Breast Cancer and Gastric Cancer | completed | Phase 1 | 63 | Jiangsu Alphamab Biopharmaceuticals Co., LtdINDUSTRY | 1 | Mar 12, 2024 | clinicaltrials |
| NCT04834778 | A Study of HC-5404-FU to Establish the Maximum Tolerated Dose (MTD) | completed | Phase 1 | 23 | HiberCell, Inc.INDUSTRY | 1 | Mar 8, 2024 | clinicaltrials |
| NCT06161233 | Pilot Study of the eHealth Application "Cancer Patients Better Life Experience" (CAPABLE) - Italy(CAPABLE-IT) | completed | N/A | 56 | Istituti Clinici Scientifici Maugeri SpAOTHER | 1 | Mar 8, 2024 | clinicaltrials |
| NCT03343301 | A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer(FIGHT) | completed | Phase 1 | 12 | Five Prime Therapeutics, Inc.INDUSTRY | 1 | Feb 28, 2024 | clinicaltrials |
| NCT03694522 | A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer(FIGHT) | completed | Phase 2 | 155 | Five Prime Therapeutics, Inc.INDUSTRY | 18 | Feb 28, 2024 | clinicaltrials |
| NCT03751761 | GC 2nd Line Durvalumab(MEDI4736)/Tremelimumab Plus Paclitaxel Study | completed | Phase 1 / Phase 2 | 58 | Asan Medical CenterOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT06281379 | Complete Mesogastric Excision With D2 Lympadenectomy for Gastric Cancer: | completed | N/A | 37 | Başakşehir Çam & Sakura City HospitalOTHER_GOV | 1 | Feb 28, 2024 | clinicaltrials |
| NCT06282484 | A Study on the Relationship Between Gastric Xanthoma and Gastric Cancer and Precancerous Lesions | completed | — | 1,260 | Xijing Hospital of Digestive DiseasesOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT02830594 | Pembrolizumab and Palliative Radiation Therapy in Treating Patients With Metastatic Esophagus, Stomach, or Gastroesophageal Junction Cancer | completed | Phase 2 | 14 | City of Hope Medical CenterOTHER | 1 | Feb 20, 2024 | clinicaltrials |
| NCT02918162 | Perioperative Chemo and Pembrolizumab in Gastric Cancer | completed | Phase 2 | 49 | Gulam ManjiOTHER | 1 | Feb 15, 2024 | clinicaltrials |
| NCT03990025 | Linked Color Imaging vs White Light Imaging for Detection of Gastric Cancer Precursors | completed | N/A | 90 | Changi General HospitalOTHER | 1 | Feb 15, 2024 | clinicaltrials |
| NCT05083338 | Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic Intraoperative Chemotherapy | completed | — | 24 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 13, 2024 | clinicaltrials |
| NCT03283761 | FOLFOX-A in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction Adenocarcinoma | completed | Phase 2 | 39 | Al B. Benson, III, MDOTHER | 1 | Feb 6, 2024 | clinicaltrials |
| NCT04074343 | TAS-102 and Irinotecan in 2L+ Gastric and Gastroesophageal Adenocarcinoma | completed | Phase 1 | 20 | University of California, IrvineOTHER | 1 | Feb 2, 2024 | clinicaltrials |
| NCT06238752 | First-line Apatinib Combined With Tislelizumab and Chemotherapy for Advanced GC(RENMIN-213) | completed | Phase 2 | 33 | Renmin Hospital of Wuhan UniversityOTHER | 1 | Feb 2, 2024 | clinicaltrials |
| NCT04770623 | Docetaxel and Irinotecan in Gastric Cancer | completed | Phase 2 | 32 | Menoufia UniversityOTHER | 1 | Jan 30, 2024 | clinicaltrials |
| NCT03196232 | Epacadostat and Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Junction or Gastric Cancer | completed | Phase 2 | 3 | George Albert FisherOTHER | 1 | Jan 23, 2024 | clinicaltrials |
| NCT06208046 | Predict 5-Year Survival in Elderly Gastric Cancer | completed | — | 2,187 | Fujian Medical UniversityOTHER | 1 | Jan 17, 2024 | clinicaltrials |
| NCT06205173 | Explored About Temperature Packing Care to Improve the Quality of Life for Chemotherapy Induced Peripheral Neuropathy (CIPN) in Colorectal Cancer and Gastric Cancer Patient | completed | N/A | 18 | National Taiwan University HospitalOTHER | 1 | Jan 12, 2024 | clinicaltrials |
| NCT03472365 | A Study of SHR-1210 in Combination With Capecitabine + Oxaliplatin or Apatinib in Treatment of Advanced Gastric Cancer | completed | Phase 2 | 67 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Jan 11, 2024 | clinicaltrials |
| NCT00486356 | Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer | completed | Phase 1 | 46 | University of NebraskaOTHER | 1 | Jan 3, 2024 | clinicaltrials |
| NCT04686747 | COVID - 19 and Advanced Gastro-intestinal Cancer Treatment(COVID - AGICT) | completed | — | 2,000 | S.M. Misericordia HospitalOTHER | 1 | Jan 3, 2024 | clinicaltrials |
| NCT06185907 | In-hospital Outcomes of Older Patients With Gastric Cancer and Their Risk Factors(GGC-01) | completed | — | 3,238 | Ruijin HospitalOTHER | 1 | Dec 29, 2023 | clinicaltrials |
| NCT03783936 | Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas | completed | Phase 2 | 18 | Ashwin SomasundaramOTHER | 1 | Dec 19, 2023 | clinicaltrials |
| NCT03607656 | The Effect of Traditional Chinese Treatment Combined Adjuvant Chemotherapy in IIIb and IIIc Gastric Cancer(CHANGE) | completed | Phase 2 / Phase 3 | 270 | Shanghai University of Traditional Chinese MedicineOTHER | 1 | Dec 18, 2023 | clinicaltrials |
| NCT05606094 | Real-World Observational Study to Describe Treatment Patterns in Patients With HER2-Positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer in East Asia | completed | — | 450 | Daiichi Sankyo Co., Ltd.INDUSTRY | 4 | Dec 15, 2023 | clinicaltrials |
| NCT01515748 | Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric Cancer(PRODIGY) | completed | Phase 3 | 530 | SanofiINDUSTRY | 1 | Dec 13, 2023 | clinicaltrials |
| NCT03618758 | Intraperitoneal Paclitaxel Plus Systemic mFOLFOX6(IPLUS) | completed | Phase 1 / Phase 2 | 35 | Seoul National University Bundang HospitalOTHER | 1 | Dec 5, 2023 | clinicaltrials |
| NCT04227951 | Gastrectomy With or Without Drainage (ADiGe)?(ADiGe) | completed | N/A | 404 | Azienda Ospedaliera Universitaria Integrata VeronaOTHER | 1 | Nov 30, 2023 | clinicaltrials |
| NCT04384575 | Study on the Effectiveness of Gastroscope Operation Quality Control Based on Artificial Intelligence Technology | completed | — | 1,570 | Peking UniversityOTHER | 1 | Nov 29, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Apr 30, 2024source: clinicaltrials